Limited Coverage Drugs – Ixekizumab

Generic Name:



80 mg/1 mL


solution for subcutaneous injection in a pre-filled syringe or pre-filled auto-injector

Special Authority Criteria

Approval Period

Treatment of moderate to severe Plaque Psoriasis, according to established criteria*, when prescribed by a dermatologist.

First approval: 12 weeks

Renewal: 1 year

* For the full criteria, see the relevant Special Authority Form below.

Practitioner Exemptions

  • No practitioner exemptions.

Special Notes

  • PharmaCare covers a maximum of 28 days per fill for ixekizumab.

Special Authority Request Form(s)